Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2012
At a glance
- Drugs ONO 5129 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 14 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov
- 30 Sep 2006 New trial record.